SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $QNCX #biotech–Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that Dirk Thye, M.D., Quince’s Chief Executive Officer and Chief Medical Officer, will participate in a fireside chat at the Oppenheimer 35th Annual Healthcare Life Sciences Conference, a virtual event, on Wednesday, February 12, 2025 beginning at 2:00 p.m. Easter
More in Uncategorized
Uncategorized
73% of Organizations with up to 2,000 Employees Rely on MSPs to Manage the Security Challenges of Growth
New International Research Shows Companies Struggle with IT Complexity, Spiraling Tool Sprawl and ...
Uncategorized
eScan Introduces Revolutionary Workspace Tenant Control – Ensuring Corporate Data Stays within Corporate Boundaries
~Seamless Productivity Meets Enterprise-Grade Security in a Hybrid Work Era~ Mumbai, July 18, ...
Uncategorized
Microvast Unveils Next-Gen Battery Solutions at Smart Energy Week 2025
STAFFORD, Texas–(BUSINESS WIRE)–Microvast Holdings, Inc. (NASDAQ: MVST) (“Microvast” or the “Company”), a global ...
